Invention Grant
US07732491B2 Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
失效
用PARP抑制剂单独或与抗肿瘤剂组合治疗乳腺癌
- Patent Title: Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
- Patent Title (中): 用PARP抑制剂单独或与抗肿瘤剂组合治疗乳腺癌
-
Application No.: US12269024Application Date: 2008-11-11
-
Publication No.: US07732491B2Publication Date: 2010-06-08
- Inventor: Barry M. Sherman , Charles Bradley , Valeria S. Ossovskaya
- Applicant: Barry M. Sherman , Charles Bradley , Valeria S. Ossovskaya
- Applicant Address: US CA Brisbane
- Assignee: BiPar Sciences, Inc.
- Current Assignee: BiPar Sciences, Inc.
- Current Assignee Address: US CA Brisbane
- Agency: Morrison & Foerster LLP
- Main IPC: A61K31/166
- IPC: A61K31/166
Abstract:
In one aspect, the present invention provides a method of treating breast cancer that is negative for at least one of ER, PR, or HER2, comprising administering to a subject at least one PARP inhibitor. In another aspect, the present invention provides a method of treating breast cancer comprising administering to a subject at least one PARP inhibitor in combination with at least one anti-tumor agent.
Public/Granted literature
- US20090131529A1 TREATMENT OF BREAST CANCER WITH A PARP INHIBITOR ALONE OR IN COMBINATION WITH ANTI-TUMOR AGENTS Public/Granted day:2009-05-21
Information query
